Uneibless Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 4.00 Cr
- Company Age 3 Year, 2 Months
- Satisfied Charges ₹ 8.00 Cr
About Uneibless Biotech
Uneibless Biotech Private Limited (UBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 November 2021 (Three years and two months 25 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company has closed loans amounting to ₹8.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vivek Wayse, Anandrao Gawade, and Sachin Swami serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33100PN2021PTC205994
-
Company No.
205994
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Nov 2021
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Uneibless Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Wayse
|
Additional Director | 18-Jan-2022 | Current |
|
Anandrao Gawade
|
Additional Director | 07-Apr-2022 | Current |
|
Sachin Swami
|
Additional Director | 30-May-2022 | Current |
Financial Performance of Uneibless Biotech.
Enhance accessibility to Uneibless Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uneibless Biotech?
Unlock access to Uneibless Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vitawise Pharma Private LimitedAnandrao Gawade is a mutual person
-
Solraaz Renewable Energy Private Limited
Sachin Swami is a mutual person
-
Aayansh Green Energy Private Limited
Sachin Swami is a mutual person
-
Avaneesh Green Energy Private Limited
Sachin Swami is a mutual person
Charges (Loans)
₹0
₹8.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 8.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2022 | State Bank Of India | ₹8.00 Cr | Satisfied |
How Many Employees Work at Uneibless Biotech?
Uneibless Biotech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uneibless Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uneibless Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
